OK advanced warning, I'm not being political, but
Post# of 144695
![](/assets/46931549/no_avatar_available_thumb.jpg)
With the obvious timing of this morning's Pfizer vaccine announcement and now EUA for Lilly's mab, one cannot discount the fact that they perfectly coincided with election results. That is, a concerted effort to withhold good news until Biden gets elected.
This may have led to Cytodyn's receiving the "don't bother filing for EUA for m/m" response from the FDA. This makes me very optimistic now that leronlimab will get EUA at 75% interim review.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)